The FDA is widely expected to authorize the drugmaker’s one-dose shot. But the advisory committee meeting beforehand will offer a window into debate over several key issues.
The FDA is widely expected to authorize the drugmaker’s one-dose shot. But the advisory committee meeting beforehand will offer a window into debate over several key issues.
Copyright © 2024 | WordPress Theme by MH Themes